STOCK TITAN

NICE Financials

NICE NASDAQ
FY2025 annual
Revenue $2.9B +7.7% YoY
Net Income $612.1M +39.3% YoY
EPS (Diluted) $9.67 +43.0% YoY
Free Cash Flow $697.6M -12.5% YoY
Market Cap $4.9B as of Nov 20, 2026
Price / Sales 1.7x on $2.9B revenue, FY2025
Price / Earnings 8.0x on $612.1M net income, FY2025
Price / Book 1.3x on $3.9B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Feb 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NICE SEC filings page.

NICE Ltd (NICE) reported $2.9B in revenue for fiscal year 2025, up 7.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).

Rhea AI NICE FY2025

Growth is translating into wider operating margins and a lighter liability burden, but 2025 profit growth outran cash generation.

Cash conversion diverged from earnings: net income rose 39.3% in FY2025 while operating cash flow fell 13.9%. That divergence followed operating cash flow's 48.3% FY2024 surge and coincided with free cash flow falling 12.5%, so earnings growth did not translate into comparable cash growth.

Operating leverage, not richer gross economics, drove the margin improvement: revenue grew 7.7% in FY2025 while gross margin slipped 0.3 percentage points. Operating margin still widened 2.0 percentage points while SG&A rose only 3.3%, pointing to better absorption of operating costs.

The financing profile became less liability-dependent: liabilities fell 27.9% while equity rose 8.0% in FY2025. Yet goodwill increased as the asset base contracted, rising 31.9% while total assets fell 3.6%; the cleaner liability profile also reflects a more goodwill-heavy balance sheet.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 72 / 100
Financial Health Score 72/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of NICE Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
83

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. NICE Ltd scores 83/100 on it among other operating companies.

Growth
67

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. NICE Ltd scores 67/100 on it among other operating companies.

Leverage
70

NICE Ltd carried $0.32 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2025. With no long-term debt figure for fiscal year 2025, NICE Ltd is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 70/100 among other operating companies measured the same way.

Liquidity
45

NICE Ltd held $1.55 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.55. Liquidity ranks operating companies on that ratio, and NICE Ltd scores 45/100 among other operating companies.

Cash Flow
91

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. NICE Ltd scores 91/100 on it among other operating companies.

Returns
77

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. NICE Ltd scores 77/100 on it among other operating companies.

Altman Z-Score Safe
4.40

NICE Ltd scores 4.40, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $4.9B against total liabilities of $1.2B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

NICE Ltd passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed
1.17x

For every $1 of reported earnings, NICE Ltd generates $1.17 in operating cash flow ($716.5M OCF vs $612.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.9B
YoY+7.7%
5Y CAGR+12.3%
10Y CAGR+12.3%

NICE Ltd generated $2.9B in revenue in fiscal year 2025. This represents an increase of 7.7% from the prior year.

EBITDA
$844.8M
YoY+12.5%
5Y CAGR+14.8%
10Y CAGR+14.2%

NICE Ltd's EBITDA was $844.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.5% from the prior year.

Net Income
$612.1M
YoY+39.3%
5Y CAGR+25.5%
10Y CAGR+9.0%

NICE Ltd reported $612.1M in net income in fiscal year 2025. This represents an increase of 39.3% from the prior year.

EPS (Diluted)
$9.67
YoY+43.0%
5Y CAGR+26.5%
10Y CAGR+8.6%

NICE Ltd earned $9.67 per diluted share (EPS) in fiscal year 2025. This represents an increase of 43.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$697.6M
YoY-12.5%
5Y CAGR+8.9%
10Y CAGR+11.5%

NICE Ltd generated $697.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 12.5% from the prior year.

Cash & Debt
$379.4M
YoY-21.2%
5Y CAGR-3.0%
10Y CAGR+1.5%

NICE Ltd held $379.4M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.

Shares Outstanding
60M
YoY-4.5%
5Y CAGR-0.8%
10Y CAGR+0.2%

NICE Ltd had 60M shares outstanding in fiscal year 2025. This represents a decrease of 4.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
66.4%
YoY-0.3pp
5Y change+0.5pp
10Y change-0.8pp

NICE Ltd's gross margin was 66.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.

Operating Margin
21.9%
YoY+2.0pp
5Y change+7.2pp
10Y change+4.0pp

NICE Ltd's operating margin was 21.9% in fiscal year 2025, reflecting core business profitability. This is up 2.0 percentage points from the prior year.

Net Margin
20.8%
YoY+4.7pp
5Y change+8.9pp
10Y change-7.1pp

NICE Ltd's net profit margin was 20.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.

Return on Equity
15.8%
YoY+3.6pp
5Y change+8.1pp
10Y change-2.5pp

NICE Ltd's ROE was 15.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.6 percentage points from the prior year.

Capital Allocation

R&D Spending
$360.4M
YoY0.0%
5Y CAGR+10.6%
10Y CAGR+10.9%

NICE Ltd invested $360.4M in research and development in fiscal year 2025. That is unchanged from the prior year.

Share Buybacks
$488.9M
YoY+32.4%
5Y CAGR+58.9%
10Y CAGR+21.7%

NICE Ltd spent $488.9M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 32.4% from the prior year.

Capital Expenditures
$18.9M
YoY-45.9%
5Y CAGR-4.8%
10Y CAGR+1.3%

NICE Ltd invested $18.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 45.9% from the prior year.

NICE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NICE annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Revenue$2.9B+7.7%$2.7B+15.0%$2.4B+9.0%$2.2B+13.5%$1.9B+16.6%$1.6B+4.7%$1.6B+9.0%$1.4B+8.4%$1.3B+31.2%$1.0B+9.6%$926.9M+6.3%$872.0M+6.1%$821.5M-6.5%$879.0M+10.7%$793.8M
Cost of Revenue$989.3M+8.8%$909.5M+18.4%$768.2M+12.4%$683.7M+9.5%$624.5M+11.1%$562.0M+5.7%$531.8M+7.0%$496.8M+6.0%$468.7M+38.8%$337.7M+11.2%$303.6M0.0%$303.5M+1.3%$299.6M-14.7%$351.2M+14.3%$307.3M
Gross Profit$2.0B+7.1%$1.8B+13.4%$1.6B+7.5%$1.5B+15.5%$1.3B+19.4%$1.1B+4.2%$1.0B+10.0%$947.7M+9.8%$863.5M+27.4%$677.8M+8.7%$623.3M+9.6%$568.5M+8.9%$521.9M-1.1%$527.8M+8.5%$486.5M
R&D Expenses$360.4M0.0%$360.6M+11.7%$322.7M+5.4%$306.1M+12.9%$271.2M+24.3%$218.2M+12.6%$193.7M+5.4%$183.8M+1.5%$181.1M+28.0%$141.5M+10.2%$128.5M+4.3%$123.1M+6.7%$115.4M-4.9%$121.4M+11.2%$109.1M
SG&A Expenses$949.9M+3.3%$919.2M+8.0%$851.4M-0.6%$856.4M+12.4%$761.6M+21.7%$625.8M+2.6%$609.7M+7.7%$566.3M+15.5%$490.4M+27.4%$384.9M+21.7%$316.2M+0.5%$314.5M+4.5%$301.0M-7.7%$326.3M+10.7%$294.7M
Operating Income$645.8M+18.3%$546.0M+25.4%$435.2M+29.9%$335.2M+27.0%$263.9M+9.0%$242.0M+1.4%$238.7M+20.8%$197.6M+31.7%$150.1M+11.8%$134.2M-19.2%$166.1M+56.3%$106.3M+40.9%$75.5M+65.4%$45.6M-22.7%$59.0M
EBITDA$844.8M+12.5%$751.0M+24.6%$602.6M+17.8%$511.7M+14.2%$448.0M+5.6%$424.1M+2.9%$411.9M+16.1%$354.8M+15.8%$306.4M+44.5%$212.0M-5.4%$224.1M+24.7%$179.6M+7.7%$166.8M+18.2%$141.1M+12.0%$126.0M
Interest Expense$0-100.0%$46K-95.8%$1.1M-2.3%$1.1M-88.8%$10.1M+29.5%$7.8M-33.5%$11.7M+4.3%$11.2M+17.0%$9.6M+414.8%$1.9M+2719.7%$66K-9.6%$73K-59.9%$182K+76.7%$103K-37.6%$165K
Income Tax$91.9M-43.3%$162.2M+35.9%$119.4M+50.4%$79.4M+91.8%$41.4M+1.4%$40.8M-15.6%$48.4M+76.7%$27.4Mn/m-$13.6M-163.7%$21.4M-30.6%$30.8M+211.2%$9.9M-63.2%$26.9Mn/m-$14.0M-213.0%$12.4M
Net Income$612.1M+39.3%$439.5M+30.6%$336.5M+26.9%$265.1M+32.8%$199.6M+1.5%$196.7M+5.8%$185.9M+16.7%$159.3M+11.2%$143.3M+22.6%$116.9M-54.8%$258.8M+151.1%$103.1M+86.5%$55.3M-18.6%$67.9M+18.6%$57.3M
EPS (Basic)$9.82+40.9%$6.97+31.0%$5.32+27.6%$4.17+32.4%$3.15+0.6%$3.13+4.7%$2.99+15.0%$2.60+9.7%$2.37+20.9%$1.96-54.9%$4.35+150.0%$1.74+89.1%$0.92-17.1%$1.11+22.0%$0.91
EPS (Diluted)$9.67+43.0%$6.76+32.3%$5.11+27.8%$4.00+34.2%$2.980.0%$2.98+3.5%$2.88+14.3%$2.52+9.1%$2.31+20.3%$1.92-54.5%$4.22+149.7%$1.69+89.9%$0.89-18.3%$1.09+22.5%$0.89
Diluted Shares (Avg)63M-3.3%66M-1.1%66M-0.3%66M-0.6%67M+1.4%66M+2.0%65M+2.1%63M+1.9%62M+1.8%61M-0.4%61M+0.6%61M-1.5%62M-0.7%62MN/A

NICE Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NICE annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Total Assets$5.1B-3.6%$5.3B+3.5%$5.1B+5.4%$4.9B+3.1%$4.7B+11.3%$4.2B+17.3%$3.6B+12.6%$3.2B+12.7%$2.8B+8.1%$2.6B+42.3%$1.8B+13.3%$1.6B-1.5%$1.7B-0.2%$1.7B+5.0%$1.6B
Current Assets$1.4B-44.9%$2.5B+8.3%$2.3B-4.3%$2.4B+5.2%$2.3B+18.3%$1.9B+121.8%$875.7M+1.7%$861.2M+24.3%$693.1M+36.1%$509.2M-22.3%$655.2M+35.0%$485.5M+5.4%$460.6M-11.6%$521.1M-4.1%$543.2M
Cash & Equivalents$379.4M-21.2%$481.7M-5.9%$511.8M-3.4%$529.6M+39.9%$378.7M-14.4%$442.3M+93.7%$228.3M-5.7%$242.1M-26.3%$328.3M+109.1%$157.0M-51.8%$325.9M+73.8%$187.5M+56.8%$119.5M+21.2%$98.6M-51.8%$204.4M
Short-Term Investments$38.0M-96.7%$1.1B+27.2%$896.0M-14.0%$1.0B-0.4%$1.0B+2.4%$1.0B+384.7%$210.8M-13.5%$243.7M+281.1%$64.0M+111.1%$30.3M-69.5%$99.2M+50.9%$65.7M-20.6%$82.8M-58.6%$200.0M+38.9%$144.0M
InventoryN/AN/AN/AN/AN/AN/A$3.4M-1.3%$3.4M-11.7%$3.9M-17.5%$4.7M-23.9%$6.2M-11.1%$7.0M-48.2%$13.4M-3.2%$13.9M+3.7%$13.4M
Accounts Receivable$738.0M+14.6%$644.0M+10.1%$585.2M+12.9%$518.5M+31.1%$395.6M+30.5%$303.1M-5.2%$319.6M+11.0%$288.0M+24.8%$230.7M-11.3%$260.2M+46.7%$177.3M+13.9%$155.6M-17.8%$189.3M+21.8%$155.4M+22.4%$127.0M
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0-100.0%$542.4M+121.4%$245.0M+84.5%$132.8M+34.5%$98.7M-75.5%$403.2M+63.4%$246.7M+2.5%$240.8M+64.7%$146.2M-31.7%$214.1M
Goodwill$2.4B+31.9%$1.8B+1.5%$1.8B+12.7%$1.6B+0.6%$1.6B+6.9%$1.5B+9.1%$1.4B+0.9%$1.4B+3.6%$1.3B+2.6%$1.3B+97.3%$651.1M-1.3%$659.7M-1.6%$670.2M-3.6%$695.0M+14.1%$609.2M
Total Liabilities$1.2B-27.9%$1.7B-4.0%$1.8B-2.0%$1.8B-3.9%$1.9B+13.0%$1.7B+23.4%$1.4B+13.6%$1.2B+8.7%$1.1B-2.2%$1.1B+157.9%$434.5M+3.6%$419.5M-7.2%$452.3M-3.7%$469.9M+11.0%$423.2M
Current Liabilities$887.6M-39.8%$1.5B+31.6%$1.1B-1.8%$1.1B-10.1%$1.3B+21.6%$1.0B+11.0%$941.0M+50.6%$624.9M+19.4%$523.4M+10.7%$472.8M+24.8%$378.8M+0.1%$378.4M-1.5%$384.2M+0.2%$383.4M+3.7%$369.6M
Non-Current Liabilities$341.9M+56.6%$218.3M-66.0%$642.8M-2.3%$657.8M+9.1%$602.9M+0.5%$600.0M+45.7%$411.7M-27.2%$565.8M-1.1%$572.2M-11.7%$647.7M+1064.5%$55.6M+35.3%$41.1M-39.6%$68.1M-21.2%$86.4M+61.4%$53.6M
Long-Term DebtN/A$0-100.0%$457.1M+0.4%$455.4M+6.1%$429.3M+1.9%$421.3M+97.5%$213.3M-53.2%$456.0M+1.9%$447.6M+0.8%$444.0MN/AN/AN/AN/AN/A
Total Equity$3.9B+8.0%$3.6B+7.4%$3.3B+9.8%$3.0B+7.7%$2.8B+10.2%$2.6B+13.6%$2.3B+11.9%$2.0B+15.3%$1.7B+15.8%$1.5B+6.8%$1.4B+16.6%$1.2B+0.7%$1.2B+1.2%$1.2B+2.8%$1.2B
Retained Earnings$3.3B+22.7%$2.7B+19.4%$2.3B+17.5%$1.9B+16.5%$1.7B+13.7%$1.5B+15.6%$1.3B+17.3%$1.1B+26.0%$850.8M+19.7%$710.9M+12.5%$632.2M+53.6%$411.6M+18.7%$346.7M+8.2%$320.4M+26.9%$252.5M

NICE Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NICE annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Operating Cash Flow$716.5M-13.9%$832.6M+48.3%$561.4M+17.0%$479.7M+3.9%$461.8M-3.8%$480.3M+28.4%$374.2M-5.7%$396.6M+0.5%$394.7M+72.9%$228.2M-9.6%$252.3M+38.4%$182.3M+46.7%$124.3M-8.4%$135.6M-12.1%$154.4M
Depreciation & Amortization$199.0M-2.9%$205.0M+22.5%$167.4M-5.2%$176.5M-4.1%$184.1M+1.1%$182.0M+5.1%$173.2M+10.2%$157.1M+0.5%$156.3M+100.9%$77.8M+34.2%$58.0M-21.0%$73.3M-19.7%$91.4M-4.3%$95.5M+42.6%$67.0M
Stock-Based Compensation$146.0M-19.8%$182.1M+3.1%$176.7M-3.3%$182.7M+19.4%$153.0M+50.5%$101.7M+25.7%$80.9M+20.3%$67.2M+18.0%$57.0M+40.5%$40.5M+42.5%$28.5M-4.6%$29.8M+13.3%$26.3M+11.4%$23.6M+11.6%$21.2M
Capital Expenditures$18.9M-45.9%$35.0M+19.7%$29.2M-8.4%$31.9M+28.8%$24.8M+2.4%$24.2M-11.4%$27.3M-13.2%$31.4M-21.2%$39.9M+46.2%$27.3M+64.4%$16.6M-0.8%$16.7M-17.3%$20.2M-29.5%$28.7M+65.8%$17.3M
Free Cash Flow$697.6M-12.5%$797.7M+49.9%$532.2M+18.8%$447.8M+2.5%$437.0M-4.2%$456.1M+31.5%$346.9M-5.0%$365.2M+2.9%$354.8M+76.6%$200.9M-14.8%$235.7M+42.4%$165.5M+59.1%$104.0M-2.7%$106.9M-22.0%$137.1M
Investing Cash Flow$160.0Mn/m-$397.4Mn/m-$293.6Mn/m-$152.4Mn/m-$261.5Mn/m-$465.1Mn/m-$344.3Mn/m-$460.8Mn/m-$213.0Mn/m-$800.0Mn/m-$28.4MN/AN/A-$164.4M-1840.4%$9.4M
Financing Cash Flow-$984.3Mn/m-$456.6Mn/m-$290.3Mn/m-$164.5Mn/m-$261.8M-233.0%$196.8Mn/m-$42.7Mn/m-$16.3Mn/m-$14.8M-103.7%$405.4Mn/m-$79.4MN/AN/A-$76.6Mn/m-$68.8M
Dividends PaidN/AN/AN/AN/AN/AN/A$0n/m$0-100.0%$9.6M-74.8%$38.2M-0.1%$38.2M+0.3%$38.1M+31.5%$29.0MN/AN/A
Share Buybacks$488.9M+32.4%$369.2M+28.0%$288.4M+99.0%$144.9M+98.1%$73.2M+51.6%$48.3M+2.1%$47.3M+81.8%$26.0M+6.5%$24.4M-44.0%$43.6M-36.2%$68.4M-27.5%$94.3M+18.7%$79.4M-25.8%$107.0M+11.6%$95.9M

NICE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NICE annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Gross Margin66.4%-0.3pp66.8%-0.9pp67.7%-1.0pp68.7%+1.2pp67.5%+1.6pp65.9%-0.3pp66.2%+0.6pp65.6%+0.8pp64.8%-1.9pp66.7%-0.5pp67.3%+2.1pp65.2%+1.7pp63.5%+3.5pp60.0%-1.2pp61.3%
Operating Margin21.9%+2.0pp20.0%+1.6pp18.3%+2.9pp15.4%+1.6pp13.7%-1.0pp14.7%-0.5pp15.2%+1.5pp13.7%+2.4pp11.3%-1.9pp13.2%-4.7pp17.9%+5.7pp12.2%+3.0pp9.2%+4.0pp5.2%-2.2pp7.4%
Net Margin20.8%+4.7pp16.1%+1.9pp14.1%+2.0pp12.2%+1.8pp10.4%-1.5pp11.9%+0.1pp11.8%+0.8pp11.0%+0.3pp10.8%-0.7pp11.5%-16.4pp27.9%+16.1pp11.8%+5.1pp6.7%-1.0pp7.7%+0.5pp7.2%
Return on Equity15.8%+3.6pp12.2%+2.2pp10.1%+1.4pp8.7%+1.7pp7.1%-0.6pp7.7%-0.6pp8.2%+0.3pp7.9%-0.3pp8.2%+0.5pp7.7%-10.6pp18.3%+9.8pp8.5%+3.9pp4.6%-1.1pp5.7%+0.8pp4.9%
Return on Assets12.0%+3.7pp8.3%+1.7pp6.6%+1.1pp5.5%+1.2pp4.2%-0.4pp4.7%-0.5pp5.1%+0.2pp5.0%-0.1pp5.0%+0.6pp4.4%-9.6pp14.0%+7.7pp6.3%+3.0pp3.3%-0.8pp4.1%+0.5pp3.6%
Current Ratio1.55-0.1x1.70-0.4x2.06-0.1x2.12+0.3x1.810.0x1.86+0.9x0.93-0.4x1.38+0.1x1.32+0.2x1.08-0.7x1.73+0.4x1.28+0.1x1.20-0.2x1.36-0.1x1.47
Debt-to-EquityN/A0.00-0.1x0.140.0x0.150.0x0.150.0x0.16+0.1x0.09-0.1x0.230.0x0.260.0x0.29N/AN/AN/AN/AN/A
Liabilities-to-Equity0.32-0.2x0.48-0.1x0.53-0.1x0.60-0.1x0.670.0x0.65+0.1x0.600.0x0.590.0x0.63-0.1x0.74+0.4x0.310.0x0.350.0x0.380.0x0.390.0x0.37
Asset Turnover0.58+0.1x0.52+0.1x0.460.0x0.450.0x0.410.0x0.390.0x0.440.0x0.450.0x0.47+0.1x0.39-0.1x0.500.0x0.530.0x0.500.0x0.530.0x0.50
FCF Margin23.7%-5.5pp29.2%+6.8pp22.4%+1.9pp20.5%-2.2pp22.8%-4.9pp27.7%+5.6pp22.0%-3.2pp25.3%-1.3pp26.6%+6.8pp19.8%-5.6pp25.4%+6.5pp19.0%+6.3pp12.7%+0.5pp12.2%-5.1pp17.3%

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
NICE Ltd NICE FY2025 $2.9B $612.1M 20.8% $4.9B 72/100
Pegasystems Inc PEGA FY2025 $1.7B $393.4M 22.5% $4.5B 57/100
Open Text Corp OTEX FY2026 $5.2B $643.0M 12.3% $5.5B 45/100
RingCentral, Inc. RNG FY2025 $2.5B $43.4M 1.7% $5.6B 50/100
BILL Holdings, Inc. BILL FY2026 $1.7B -$11.2M -0.7% $5.3B 53/100
Braze, Inc. BRZE FY2026 $738.2M -$131.3M -17.8% $5.3B 45/100

Frequently Asked Questions

NICE Ltd (NICE) reported $2.9B in total revenue for fiscal year 2025. This represents a 7.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

NICE Ltd (NICE) revenue grew by 7.7% year-over-year, from $2.7B to $2.9B in fiscal year 2025.

Yes, NICE Ltd (NICE) reported a net income of $612.1M in fiscal year 2025, with a net profit margin of 20.8%.

NICE Ltd (NICE) reported diluted earnings per share of $9.67 for fiscal year 2025. This represents a 43.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NICE Ltd (NICE) had EBITDA of $844.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

NICE Ltd (NICE) had a gross margin of 66.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

NICE Ltd (NICE) had an operating margin of 21.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

NICE Ltd (NICE) had a net profit margin of 20.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

NICE Ltd (NICE) has a return on equity of 15.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

NICE Ltd (NICE) generated $697.6M in free cash flow during fiscal year 2025. This represents a -12.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

NICE Ltd (NICE) generated $716.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

NICE Ltd (NICE) had $5.1B in total assets as of fiscal year 2025, including both current and long-term assets.

NICE Ltd (NICE) invested $18.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

NICE Ltd (NICE) invested $360.4M in research and development during fiscal year 2025.

Yes, NICE Ltd (NICE) spent $488.9M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

NICE Ltd (NICE) had 60M shares outstanding as of fiscal year 2025.

NICE Ltd (NICE) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

NICE Ltd (NICE) had a liabilities-to-equity ratio of 0.32 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

NICE Ltd (NICE) had a return on assets of 12.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

NICE Ltd (NICE) trades at 8.0x earnings, its market capitalization divided by $612.1M net income, FY2025. The market capitalization is $4.9B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

NICE Ltd (NICE) trades at 1.7x sales, its market capitalization divided by $2.9B revenue, FY2025. The market capitalization is $4.9B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

NICE Ltd (NICE) has an Altman Z-Score of 4.40, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

NICE Ltd (NICE) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

NICE Ltd (NICE) has an earnings quality ratio of 1.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

NICE Ltd (NICE) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top